Weight-loss drug fattens heart risks.

Suppr

超能文献

出版信息

Consum Rep. 2003 Dec;68(12):57.

PMID:14680011

Abstract

摘要

相似文献

Weight-loss drug fattens heart risks.

Consum Rep. 2003 Dec;68(12):57.

[The trial that killed a drug].

Lakartidningen. 2010;107(39):2339.

Sibutramine: balancing weight loss benefit and possible cardiovascular risk.

Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):337-41. doi: 10.1016/j.numecd.2008.03.008. Epub 2008 May 27.

Sibutramine--another flawed diet pill.

N Engl J Med. 2010 Sep 2;363(10):972-4. doi: 10.1056/NEJMe1007993.

Long-term pharmacotherapy for obesity.

Obes Res. 2004 Dec;12 Suppl:163S-6S. doi: 10.1038/oby.2004.283.

[No progress without the physician in therapy of obesity].

MMW Fortschr Med. 2000 Jan 27;142(4):35-6.

Withdrawal of sibutramine in Europe.

BMJ. 2010 Feb 9;340:c824. doi: 10.1136/bmj.c824.

[The principle of precaution and the drug treatment of obese subjects].

Med Clin (Barc). 1999 Apr 17;112(13):503-7.

Sibutramine (Meridia) withdrawn.

Med Lett Drugs Ther. 2010 Nov 1;52(1350):88.

Serotonin syndrome risk with antiobesity drug.

Can J Clin Pharmacol. 2000 Winter;7(4):216.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Weight-loss drug fattens heart risks.

Consum Rep. 2003 Dec;68(12):57.

[The trial that killed a drug].

Lakartidningen. 2010;107(39):2339.

Sibutramine: balancing weight loss benefit and possible cardiovascular risk.

Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):337-41. doi: 10.1016/j.numecd.2008.03.008. Epub 2008 May 27.

Sibutramine--another flawed diet pill.

N Engl J Med. 2010 Sep 2;363(10):972-4. doi: 10.1056/NEJMe1007993.

Long-term pharmacotherapy for obesity.

Obes Res. 2004 Dec;12 Suppl:163S-6S. doi: 10.1038/oby.2004.283.

[No progress without the physician in therapy of obesity].

MMW Fortschr Med. 2000 Jan 27;142(4):35-6.

Withdrawal of sibutramine in Europe.

BMJ. 2010 Feb 9;340:c824. doi: 10.1136/bmj.c824.

[The principle of precaution and the drug treatment of obese subjects].

Med Clin (Barc). 1999 Apr 17;112(13):503-7.

Sibutramine (Meridia) withdrawn.

Med Lett Drugs Ther. 2010 Nov 1;52(1350):88.

Serotonin syndrome risk with antiobesity drug.

Can J Clin Pharmacol. 2000 Winter;7(4):216.